Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinomaAswathy R. Devan, Lekshmi R. Nath, K Pavithran et al.|World Journal of Gastroenterology|2022Cited by 37
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevanceMeena Murali, Lekshmi R. Nath, Ayana R. Kumar et al.|Clinical & Translational Oncology|2021Cited by 17